ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Internal Medicine

Top Internal Medicine Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHARLES HARPER MD

Internal Medicine

27,616

$1.38M

861
732 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $53

PAUL WIBBELS MD

Internal Medicine

26,352

$1.2M

801
676 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $53

SCOTT SMITH M.D.

Internal Medicine

25,783

$1.29M

844
711 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $53

DAVID SHARP D.O.

Internal Medicine

23,842

$1.34M

799
647 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $53

RICHARD FRENCH MD

Internal Medicine

22,792

$1.05M

753
687 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $53

RICHARD OSTERHOLM M.D.

Internal Medicine

22,269

$1.32M

894
791 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $53

WILLIAM SANDY M.D,

Internal Medicine

22,136

$909K

618
558 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $53

TIMOTHY STIVRINS MD

Internal Medicine

21,007

$888K

628
587 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $53

ARIF SATTAR M.D.

Internal Medicine

19,104

$1.05M

510
443 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $53

THOMAS SMITH M.D.

Internal Medicine

18,672

$851K

509
460 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $53

MARK NIELSEN M.D.

Internal Medicine

18,600

$978K

702
616 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $53

JOSEPH SHEHAN M.D.

Internal Medicine

17,819

$911K

757
624 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $53

TERENCE COONEY M.D.

Internal Medicine

16,777

$776K

707
622 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $53

RICHARD SEITZ MD

Internal Medicine

16,571

$703K

556
485 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $53

SUSAN SCHOLER M.D.

Internal Medicine

16,160

$960K

656
591 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $53

KENNETH CHELOHA MD

Internal Medicine

15,904

$708K

600
533 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $53

KATHRYN HAJJ MD

Internal Medicine

15,788

$847K

601
436 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $53

DAVID COLAN M.D.

Internal Medicine

15,510

$965K

654
567 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $53

TRAVIS HAGEMAN M.D.

Internal Medicine

15,273

$844K

504
443 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $53

DONALD WELDON

Internal Medicine

15,126

$661K

538
429 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $53

PAUL ZUERCHER MD

Internal Medicine

15,060

$682K

658
613 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $53

EDWARD TAYLOR M.D.

Internal Medicine

15,047

$824K

724
630 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $53

DAVID LITTLE MD

Internal Medicine

14,729

$610K

467
429 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $53

KIMBERLY MICKELS M.D.

Internal Medicine

14,686

$752K

459
394 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $53

GREGORY SCHAFER M.D.

Internal Medicine

14,269

$533K

595
538 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank